ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 955

Myeloid Deletion Of SIRT1 Aggravates Serum Transfer Arthritis But Ameliorate Collagen-Induced Arthritis

Sang-Il Lee1, Yun-Hong Cheon2, Won Seok Lee2 and Ji-Min Kim3, 1Division of Rheumatology, Department of Internal Medicine, Gyeongsang National University School of Medicine, Jinju, South Korea, 2Rheumatology, Department of Internal Medicine, Chonbuk National University Medical School and Research Institute of Clinical Medicine, Jeonju, South Korea, 3Division of Rheumatology, Department of Internal Medicine, Keimyung University School of Medicine, Daegu, South Korea

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Animal models, Collagen, osteoclasts, rheumatoid arthritis (RA) and rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Cytokines, Mediators, Cell-cell Adhesion, Cell Trafficking and Angiogenesis I

Session Type: Abstract Submissions (ACR)

Background/Purpose: SIRT1 plays a pivotal role in regulating the inflammatory response. Thus, we assessed the role of SIRT1 in K/BxN serum transfer arthritis as a model of inflammatory arthritis using a myeloid cell-specific SIRT1 knockout (mSIRT1 KO) mouse. To further understand how SIRT1 regulates autoimmunity, we also evaluated collagen-induced arthritis (CIA) using mSIRT1 KO mice.

Methods: mSIRT1 KO mice were generated by using the loxP/Cre recombinase system. K/BxN serum transfer arthritis and CIA were induced in mSIRT1 KO (SIRT1loxP/loxP LysM-Cre+/+) and their age-matched littermate loxP control (SIRT1loxP/loxP LysM-Cre-/-) mice. Arthritis severity was assessed by clinical and pathological scoring. The levels of inflammatory cytokines in the serum and joints were measured by ELISA and quantitative polymerase chain reaction. The migration, M1 polarization, cytokine production, osteoclastogenesis, and p65 acetylation were assessed in bone marrow-derived monocytes/macrophages (BMMs). The each subset of T cells and dendritic cells was analyzed by flow cytofluorometry in lymph node and spleen.

Results: The mSIRT1 KO mice showed more severe inflammatory arthritis accompanied by aggravated pathological findings than control in K/BxN serum transfer model. These effects were paralleled by higher levels of IL-1 and TNF-α and increased TRAP-positive osteoclasts and F4/80+ macrophages in the synovium of mSIRT1 KO mice. BMMs from the mSIRT1 mice displayed hyperacetylated p65 and increased NF-κB binding activity than control. However, unlike passive K/BxN arthritis, SIRT1 deficiency in CIA was associated with lower arthritic, radiographic, and pathologic severity. These effects were paralleled by lower levels of numerous inflammatory cytokines in the ankles and lymph nodes of mSIRT1 KO mice. In CIA, the proportion of Th1 and Th17 cells and CD80/86-positive dendritic cells was significantly decreased in mSIRT1 KO mice than controls.

Conclusion: Our study suggests that SIRT1 plays a complex role in regulating inflammation and adaptive immunity and, depending on the model, either enhances or suppresses rheumatoid arthritis.


Disclosure:

S. I. Lee,
None;

Y. H. Cheon,
None;

W. S. Lee,
None;

J. M. Kim,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/myeloid-deletion-of-sirt1-aggravates-serum-transfer-arthritis-but-ameliorate-collagen-induced-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology